A meta-analysis of nine randomised controlled trials in NAFLD showed a reduction in body mass index (BMI) and an overall improvement in aminotransferase (ALT) with the use of prebiotics [20]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.